Complementary function of the two catalytic domains of APOBEC3G

Virology

Volumn 333, Issue 2, 2005, Pages 374-386

  Navarro, Francisco ^a   Bollman, Brooke ^a   Chen, Hui ^a   König, Renate ^a   Yu, Qin ^a   Chiles, Kristopher ^a   Landau, Nathaniel R ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

APOBEC3G; Deamination; Encapsidation; HIV 1; Vif

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; CYTIDINE DEAMINASE; MUTANT PROTEIN; UNCLASSIFIED DRUG; ZINC ION;

AMINO TERMINAL SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DELETION MUTANT; ENCAPSULATION; ENZYME ACTIVITY; GENE MAPPING; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1; MURINE LEUKEMIA VIRUS; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; RNA BINDING;

EID: 13844270834     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2005.01.011     Document Type: Article

References (48)

1. M.A. Accola, B. Strack, and H.G. Gottlinger Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain J. Virol. 74 12 2000 5395 5402
2. T.M. Alce, and W. Popik APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein J. Biol. Chem. 279 33 2004 34083 34086
3. A. Aldovini, and R.A. Young Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus J. Virol. 64 5 1990 1920 1926
4. R. Aronoff, and M. Linial Specificity of retroviral RNA packaging J. Virol. 65 1 1991 71 80
5. R. Berkowitz, J. Fisher, and S.P. Goff RNA packaging Curr. Top. Microbiol. Immunol. 214 1996 177 218
6. L. Betts, S. Xiang, S.A. Short, R. Wolfenden, and C.W. Carter Jr. Cytidine deaminase. The 2.3 A crystal structure of an enzyme: transition-state analog complex J. Mol. Biol. 235 2 1994 635 656
7. K.N. Bishop, R.K. Holmes, A.M. Sheehy, N.O. Davidson, S.J. Cho, and M.H. Malim Cytidine deamination of retroviral DNA by diverse APOBEC proteins Curr. Biol. 14 15 2004 1392 1396
8. H.P. Bogerd, B.P. Doehle, H.L. Wiegand, and B.R. Cullen A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor Proc. Natl. Acad. Sci. U.S.A. 101 11 2004 3770 3774
9. S. Cen, F. Guo, M. Niu, J. Saadatmand, J. Deflassieux, and L. Kleiman The interaction between HIV-1 Gag and APOBEC3G J. Biol. Chem. 279 32 2004 33177 33184
10. R.I. Connor, B.K. Chen, S. Choe, and N.R. Landau Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes Virology 206 1995 936 944
11. D. Derse, S.A. Hill, P.A. Lloyd, H. Chung, and B.A. Morse Examining human T-lymphotropic virus type 1 infection and replication by cell-free infection with recombinant virus vectors J. Virol. 75 18 2001 8461 8468
12. M. Douaisi, S. Dussart, M. Courcoul, G. Bessou, R. Vigne, and E. Decroly HIV-1 and MLV Gag proteins are sufficient to recruit APOBEC3G into virus-like particles Biochem. Biophys. Res. Commun. 321 3 2004 566 573
13. T. Dull, R. Zufferey, M. Kelly, R.J. Mandel, M. Nguyen, D. Trono, and L. Naldini A third-generation lentivirus vector with a conditional packaging system J. Virol. 72 11 1998 8463 8471
14. R.J. Gorelick, S.M. Nigida Jr., J.W. Bess Jr., L.O. Arthur, L.E. Henderson, and A. Rein Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA J. Virol. 64 7 1990 3207 3211
15. R.S. Harris, S.K. Petersen-Mahrt, and M.S. Neuberger RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators Mol. Cell 10 5 2002 1247 1253
16. R.S. Harris, K.N. Bishop, A.M. Sheehy, H.M. Craig, S.K. Petersen-Mahrt, I.N. Watt, M.S. Neuberger, and M.H. Malim DNA deamination mediates innate immunity to retroviral infection Cell 113 6 2003 803 809
17. A. Jarmuz, A. Chester, J. Bayliss, J. Gisbourne, I. Dunham, J. Scott, and N. Navaratnam An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22 Genomics 79 3 2002 285 296
18. P.P. Lau, H.J. Zhu, A. Baldini, C. Charnsangavej, and L. Chan Dimeric structure of a human apolipoprotein B mRNA editing protein and cloning and chromosomal localization of its gene Proc. Natl. Acad. Sci. U.S.A. 91 18 1994 8522 8526
19. D. Lecossier, F. Bouchonnet, F. Clavel, and A.J. Hance Hypermutation of HIV-1 DNA in the absence of the Vif protein Science 300 5622 2003 1112
20. J. Li, M.J. Potash, and D.J. Volsky Functional domains of APOBEC3G required for antiviral activity J. Cell. Biochem. 92 3 2004 560 5672
21. M.T. Liddament, W.L. Brown, A.J. Schumacher, and R.S. Harris APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo Curr. Biol. 14 15 2004 1385 1391
22. K. Luo, B. Liu, Z. Xiao, Y. Yu, X. Yu, R. Gorelick, and X.F. Yu Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging J. Virol. 78 21 2004 11841 11852
23. B. Mangeat, P. Turelli, G. Caron, M. Friedli, L. Perrin, and D. Trono Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts Nature 424 6944 2003 99 103
24. B. Mangeat, P. Turelli, S. Liao, and D. Trono A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action J. Biol. Chem. 279 15 2004 14481 14483
25. R. Mariani, D. Chen, B. Schrofelbauer, F. Navarro, R. Konig, B. Bollman, C. Munk, H. Nymark-McMahon, and N.R. Landau Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif Cell 114 1 2003 21 31
26. A. Mehle, B. Strack, P. Ancuta, C. Zhang, M. McPike, and D. Gabuzda Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway J. Biol. Chem. 279 9 2004 7792 7798
27. M. Muramatsu, K. Kinoshita, S. Fagarasan, S. Yamada, Y. Shinkai, and T. Honjo Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme Cell 102 5 2000 553 563
28. T. Muto, M. Muramatsu, M. Taniwaki, K. Kinoshita, and T. Honjo Isolation, tissue distribution, and chromosomal localization of the human activation-induced cytidine deaminase (AID) gene Genomics 68 1 2000 85 88
29. N. Navaratnam, S. Bhattacharya, T. Fujino, D. Patel, A.L. Jarmuz, and J. Scott Evolutionary origins of apoB mRNA editing: catalysis by a cytidine deaminase that has acquired a novel RNA-binding motif at its active site Cell 81 2 1995 187 195
30. P. Revy, T. Muto, Y. Levy, F. Geissmann, A. Plebani, O. Sanal, N. Catalan, M. Forveille, R. Dufourcq-Labelouse, A. Gennery, I. Tezcan, F. Ersoy, H. Kayserili, A.G. Ugazio, N. Brousse, M. Muramatsu, L.D. Notarangelo, K. Kinoshita, T. Honjo, A. Fischer, and A. Durandy Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2 Cell 102 5 2000 565 575
31. A. Schafer, H.P. Bogerd, and B.R. Cullen Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor Virology 328 2 2004 163 168
32. B. Schrofelbauer, D. Chen, and N.R. Landau A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif) Proc. Natl. Acad. Sci. U.S.A. 101 11 2004 3927 3932
33. A.M. Sheehy, N.C. Gaddis, J.D. Choi, and M.H. Malim Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein Nature 418 6898 2002 646 650
34. A.M. Sheehy, N.C. Gaddis, and M.H. Malim The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif Nat. Med. 9 11 2003 1404 1407
35. K. Shindo, A. Takaori-Kondo, M. Kobayashi, A. Abudu, K. Fukunaga, and T. Uchiyama The enzymatic activity of CEM15/Apobec-3G is essential for the regulation of the infectivity of HIV-1 virion but not a sole determinant of its antiviral activity J. Biol. Chem. 278 45 2003 44412 44416
36. Y. Soneoka, P.M. Cannon, E.E. Ramsdale, J.C. Griffiths, G. Romano, S.M. Kingsman, and A.J. Kingsman A transient three-plasmid expression system for the production of high titer retroviral vectors Nucleic Acids Res. 23 4 1995 628 633
37. K. Stopak, C. de Noronha, W. Yonemoto, and W.C. Greene HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability Mol. Cell 12 3 2003 591 601
38. E.S. Svarovskaia, H. Xu, J.L. Mbisa, R. Barr, R.J. Gorelick, A. Ono, E.O. Freed, W.S. Hu, and V.K. Pathak Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs J. Biol. Chem. 279 34 2004 35822 35828
39. P. Turelli, B. Mangeat, S. Jost, S. Vianin, and D. Trono Inhibition of hepatitis B virus replication by APOBEC3G Science 303 5665 2004 1829
40. J.E. Wedekind, G.S. Dance, M.P. Sowden, and H.C. Smith Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business Trends Genet. 19 4 2003 207 216
41. H.L. Wiegand, B.P. Doehle, H.P. Bogerd, and B.R. Cullen A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins EMBO J. 23 12 2004 2451 2458
42. H. Xu, E.S. Svarovskaia, R. Barr, Y. Zhang, M.A. Khan, K. Strebel, and V.K. Pathak A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion Proc. Natl. Acad. Sci. U.S.A. 101 15 2004 5652 5657
43. X. Yu, Y. Yu, B. Liu, K. Luo, W. Kong, P. Mao, and X.F. Yu Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex Science 302 5647 2003 1056 1060
44. Q. Yu, D. Chen, R. Konig, R. Mariani, D. Unutmaz, and N.R. Landau APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication J. Biol. Chem. 279 51 2004 53379 53386
45. Q. Yu, R. Konig, S. Pillai, K. Chiles, M. Kearney, S. Palmer, D. Richman, J.M. Coffin, and N.R. Landau Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome Nat. Struct. Mol. Biol. 11 5 2004 435 442
46. V. Zennou, D. Perez-Caballero, H. Gottlinger, and P.D. Bieniasz APOBEC3G incorporation into human immunodeficiency virus type 1 particles J. Virol. 78 21 2004 12058 12061
47. H. Zhang, B. Yang, R.J. Pomerantz, C. Zhang, S.C. Arunachalam, and L. Gao The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA Nature 424 6944 2003 94 98
48. Y.H. Zheng, D. Irwin, T. Kurosu, K. Tokunaga, T. Sata, and B.M. Peterlin Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication J. Virol. 78 11 2004 6073 6076